M&A Deal Summary |
|
---|---|
Date | 2005-06-01 |
Target | Command Alkon |
Sector | Information Technology |
Buyer(s) |
Quilvest Capital Partners
Pegasus Capital Advisors |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1972 |
PE ASSETS | 6.0B USD |
Size | Mega |
Type | Sector Agnostic |
Quilvest Capital Partners is the private equity investment arm of asset management firm Quilvest. Quilvest Capital Partners invests in private equity and debt funds as well as makes direct investments. The direct investment group looks for opportunities in the US, Europe, and 'opportunistically' in Asia with a preference for buyout, growth capital, and venture transactions. Quilvest Capital Partners will consider both minority and majority positions. Quilvest Capital Partners was established in 1972 and is based Paris.
DEAL STATS | # |
---|---|
Overall | 27 of 98 |
Sector (Information Technology) | 3 of 6 |
Type (Buyout (LBO, MBO, MBI)) | 8 of 28 |
State (Alabama) | 1 of 2 |
Country (United States) | 7 of 43 |
Year (2005) | 4 of 9 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2005-05-01 |
Laboratoires Chemineau SA
Vouvray, France Laboratoires Chemineau is an operator and manufacturer of pharmaceutical products. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2005-06-14 |
Salmedix
San Diego, California, United States Salmedix was a late stage biopharmaceutical company focusing on in-licensing and development of cancer products. The Company?s lead product, SDX-105, was in Phase II/III clinical trials for non-Hodgkin?s lymphoma at the time of Easton's investment. In addition, Salmedix had two drugs in Phase II clinical development, as well as several preclinical product candidates. |
Sell | $160M |
Category | Private Equity Firm |
---|---|
Founded | 1996 |
PE ASSETS | 900M USD |
Size | Middle-Market |
Type | Sector Agnostic |
Pegasus Capital Advisors is a private equity firm focused on providing equity and junior capital to middle-market companies across a wide variety of industries. Pegasus looks to commit between $50 and $150 million per transaction. Sectors of interest include building materials, consumer products/services, energy, financial services/insurance, IT, marketing/communications, metals/minerals, and safety/security. Pegasus was formed in 1995 and is based in Stamford, Connecticut.
DEAL STATS | # |
---|---|
Overall | 4 of 31 |
Sector (Information Technology) | 1 of 1 |
Type (Buyout (LBO, MBO, MBI)) | 3 of 24 |
State (Alabama) | 1 of 1 |
Country (United States) | 4 of 25 |
Year (2005) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2001-12-21 |
Genesis Worldwide II
Callery, Pennsylvania, United States Genesis Worldwide II, Inc. is a designs, engineers and manufactures high-quality metal coil processing equipment through its Herr-Voss Stamco business unit. The Company also provides mill roll reconditioning, texturing and grinding services in addition to its rebuild, repair and spare parts business. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2005-07-01 |
Hain Pure Protein
Fredericksburg, Pennsylvania, United States Hain Pure Protein Corp. is a provider of poultry processing facilities in Fredericksburg. Hain Pure Protein Corp. offers organic chicken, antibiotic-free chicken, cooked chicken, hot wings, diced chicken thighs, and diced chicken breast. |
Buy | - |